OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?
Fateme Babaha, Nima Rezaei
The American Journal of the Medical Sciences (2020) Vol. 360, Iss. 6, pp. 740-741
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
Kawthar Mohamed, Niloufar Yazdanpanah, Amene Saghazadeh, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104490-104490
Open Access | Times Cited: 148

A systematic review of pregnant women with COVID-19 and their neonates
Mona Mirbeyk, Amene Saghazadeh, Nima Rezaei
Archives of Gynecology and Obstetrics (2021)
Open Access | Times Cited: 130

Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review
Baoming Liu, Harry R. Hill
Journal of Interferon & Cytokine Research (2020) Vol. 40, Iss. 12, pp. 549-554
Open Access | Times Cited: 87

COVID-19 and Its Global Economic Impact
Zahra Kolahchi, Manlio De Domenico, Lucina Q. Uddin, et al.
Advances in experimental medicine and biology (2021), pp. 825-837
Closed Access | Times Cited: 79

SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best
Ane Fernandez Salinas, Eva Piano Mortari, Sara Terreri, et al.
Journal of Clinical Immunology (2021) Vol. 41, Iss. 8, pp. 1709-1722
Open Access | Times Cited: 79

SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
Haifa Khemiri, Kaouther Ayouni, Henda Triki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 63

COVID-19: Molecular and Cellular Response
Shamila D. Alipoor, Esmaeil Mortaz, Hamidreza Jamaati, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 50

COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico
Lina María Castaño‐Jaramillo, Marco Antonio Yamazaki‐Nakashimada, Patricia María O’Farrill-Romanillos, et al.
Journal of Clinical Immunology (2021) Vol. 41, Iss. 7, pp. 1463-1478
Open Access | Times Cited: 50

COVID-19 in Patients with Primary Immunodeficiency
Saliha Esenboğa, Melike Ocak, Ayşegül Akarsu, et al.
Journal of Clinical Immunology (2021) Vol. 41, Iss. 7, pp. 1515-1522
Open Access | Times Cited: 47

COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review
Emily Drzymalla, Ridgely Fisk Green, Martha Knuth, et al.
Clinical Immunology (2022) Vol. 243, pp. 109097-109097
Open Access | Times Cited: 34

The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency
Isabella Quinti, Franco Locatelli, Rita Carsetti
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 31

Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies
Kiarash Saleki, Shakila Yaribash, Mohammad Banazadeh, et al.
European Journal of Pharmacology (2021) Vol. 906, pp. 174248-174248
Open Access | Times Cited: 33

Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 24

Computed tomography scan in COVID-19: a systematic review and meta-analysis
Pouya Mahdavi Sharif, Mehran Nematizadeh, Mahdia Saghazadeh, et al.
Polish Journal of Radiology (2022) Vol. 87, pp. 1-23
Open Access | Times Cited: 22

Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations
Daniele Focosi, Massimo Franchini
Expert Review of Vaccines (2021) Vol. 21, Iss. 7, pp. 877-884
Open Access | Times Cited: 28

Nutritional Impact and Its Potential Consequences on COVID-19 Severity
Esmaeil Mortaz, Gillina F. G. Bezemer, Shamila D. Alipoor, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 23

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients
Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, et al.
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 25

Atypical course of COVID-19 in patient with Bruton agammaglobulinemia
Ivana Milošević, Jaroslava Jovanović, Olja Stevanović
The Journal of Infection in Developing Countries (2020) Vol. 14, Iss. 11, pp. 1248-1251
Open Access | Times Cited: 24

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
Elahe Aleebrahim‐Dehkordi, Faezeh Soveyzi, Niloofar Deravi, et al.
Journal of Pediatric Nursing (2020) Vol. 56, pp. 70-79
Open Access | Times Cited: 21

Health Care Policies and COVID-19 Prevalence: Is There Any Association?
Seyed Aria Nejadghaderi, Amene Saghazadeh, Nima Rezaei
International Journal of Health Services (2021) Vol. 52, Iss. 1, pp. 9-22
Open Access | Times Cited: 18

Interdisciplinary Approaches to COVID-19
Negar Moradian, Marjan Moallemian Isfahani, Farnaz Delavari, et al.
Advances in experimental medicine and biology (2021), pp. 923-936
Closed Access | Times Cited: 18

Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study
Riccardo Scarpa, Alessandro Dell’Edera, Carla Felice, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13

Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies
Mackenzie Zendt, Fausto Andres Bustos Carrillo, Sophie Kelly, et al.
Science Advances (2023) Vol. 9, Iss. 41
Open Access | Times Cited: 7

COVID‐19 AND PRIMARY IMMUNODEFICIENCY: ONE‐YEAR EXPERIENCE
Laila S Al Yazidi, Hatem Al Rawahi, Ibrahim Al Busaidi, et al.
Journal of Paediatrics and Child Health (2021) Vol. 57, Iss. 4, pp. 594-594
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top